Home > Qtrly Results > CORONA REMEDIES

CORONA REMEDIES
Quarterly Results Analysis [Jun2026]

CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹422 Cr ₹353 Cr ₹342 Cr ₹361 Cr ₹347 Cr ₹294 Cr ₹298 Cr ₹314 Cr
Expenses ₹329 Cr ₹291 Cr ₹259 Cr ₹283 Cr ₹277 Cr ₹239 Cr ₹228 Cr ₹247 Cr
Operating Income ₹93 Cr ₹62 Cr ₹83 Cr ₹78 Cr ₹70 Cr ₹54 Cr ₹69 Cr ₹67 Cr
Other Income ₹3 Cr ₹4 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹2 Cr
Interest ₹3 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹3 Cr
Depreciation ₹13 Cr ₹10 Cr ₹9 Cr ₹9 Cr ₹9 Cr ₹10 Cr ₹10 Cr ₹9 Cr
Profit Before Tax ₹80 Cr ₹54 Cr ₹55 Cr ₹70 Cr ₹61 Cr ₹43 Cr ₹58 Cr ₹57 Cr
Profit After Tax ₹60 Cr ₹45 Cr ₹41 Cr ₹52 Cr ₹46 Cr ₹31 Cr ₹45 Cr ₹43 Cr
EPS ₹9.83 ₹7.41 ₹6.75 ₹8.55 ₹7.55 ₹5.16 ₹7.35 ₹7.03
Industry Peers & Returns1W1M1Y
CORONA REMEDIES 0.6% 1.7% NA
SUN PHARMACEUTICAL INDUSTRIES -2.3% -3.3% 15.7%
DIVIS LABORATORIES 0.3% 16.3% 44.3%
TORRENT PHARMACEUTICALS 2.8% -0.5% 37.1%
CIPLA -3.1% -1.2% -5.8%
DR REDDYS LABORATORIES -2.9% -3% -3.3%
MANKIND PHARMA -1.1% -7.2% -1.7%
LUPIN -1.8% -11.7% 14.5%
ZYDUS LIFESCIENCES -5.8% -3.4% 16.8%

CORONA REMEDIES Quarterly Revenues

Revenues
Q-o-Q

19.64 %

Y-o-Y

21.90 %

Quarters Revenues % Change
Jun2026 ₹422 Cr
19.64
Mar2026 ₹353 Cr
3.12
Dec2025 ₹342 Cr
-5.18
Sep2025 ₹361 Cr
4.21
Jun2025 ₹347 Cr
18.00
Mar2025 ₹294 Cr
-1.34
Dec2024 ₹298 Cr
-5.16
Sep2024 ₹314 Cr -

CORONA REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

50.16 %

Y-o-Y

33.46 %

Quarters Operating Profit % Change
Jun2026 ₹93 Cr
50.16
Mar2026 ₹62 Cr
-25.42
Dec2025 ₹83 Cr
5.98
Sep2025 ₹78 Cr
12.45
Jun2025 ₹70 Cr
28.70
Mar2025 ₹54 Cr
-21.90
Dec2024 ₹69 Cr
3.89
Sep2024 ₹67 Cr -
Operating Margins
Q-o-Q

25.57 %

Y-o-Y

9.48 %

Quarters Operating Margin% % Change
Jun2026 22.05%
25.57
Mar2026 17.56%
-27.71
Dec2025 24.29%
11.78
Sep2025 21.73%
7.89
Jun2025 20.14%
9.10
Mar2025 18.46%
-20.84
Dec2024 23.32%
9.53
Sep2024 21.29% -

CORONA REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

33.41 %

Y-o-Y

29.53 %

Quarters Profit After Tax % Change
Jun2026 ₹60 Cr
33.41
Mar2026 ₹45 Cr
9.21
Dec2025 ₹41 Cr
-20.90
Sep2025 ₹52 Cr
12.39
Jun2025 ₹46 Cr
48.05
Mar2025 ₹31 Cr
-30.00
Dec2024 ₹45 Cr
4.16
Sep2024 ₹43 Cr -
PAT Margins
Q-o-Q

11.52 %

Y-o-Y

6.27 %

Quarters PAT Margin(%) % Change
Jun2026 14.23 %
11.52
Mar2026 12.76 %
5.89
Dec2025 12.05 %
-16.55
Sep2025 14.44 %
7.84
Jun2025 13.39 %
25.49
Mar2025 10.67 %
-29.06
Dec2024 15.04 %
9.86
Sep2024 13.69 % -

CORONA REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

32.66 %

Y-o-Y

30.20 %

Quarters EPS % Change
Jun2026 ₹9.83
32.66
Mar2026 ₹7.41
9.78
Dec2025 ₹6.75
-21.05
Sep2025 ₹8.55
13.25
Jun2025 ₹7.55
46.32
Mar2025 ₹5.16
-29.80
Dec2024 ₹7.35
4.55
Sep2024 ₹7.03 -

You may also like the below Video Courses